Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Cowen Investment Management
AddedFeb 19, 2024
UpdatedJun 28, 2026
Cowen Investment Management

Cowen Investment Management

Operating

NYC-based financial firm specializing in sustainable private equity and credit investments.

Location
New York City, NY, US
Founded
2018
Firm
Compare
Portfolio
Employees

Cowen Investment Management, based in New York City, focuses on sustainable private equity and credit investments. The firm's portfolio spans various sectors, with a notable emphasis on healthcare and biotechnology companies. While specific investment sizes are not disclosed, their involvement in multiple post-IPO equity rounds suggests a preference for later-stage investments.

The firm's portfolio includes prominent companies such as Allogene Therapeutics, Blueprint Medicines, and Canopy Growth. Cowen Investment Management leverages its expertise in financial services to support portfolio companies, potentially offering strategic guidance and access to capital markets. Their investment approach appears to prioritize sustainable and innovative businesses across different industries.

Cowen Investment Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments11
Current Portfolio Count11
Total Portfolio Exits0

Top Investment Stages

Post Ipo Equity7 (63.6%)
Series B2 (18.2%)
Convertible Note1 (9.1%)
Post Ipo Debt1 (9.1%)

Stage Mix

Post Ipo Equity 64%Series B 18%Convertible Note 9%Post Ipo Debt 9%

Concentration shown as share of disclosed investments by stage.

Recent Investments

G1 Therapeutics logo

G1 Therapeutics

Allogene Therapeutics logo

Allogene Therapeutics

Spero Therapeutics logo

Spero Therapeutics

Tellurian logo

Tellurian

Canopy Growth logo

Canopy Growth

Boston Omaha logo

Boston Omaha

Blueprint Medicines logo

Blueprint Medicines

Revance Therapeutics logo

Revance Therapeutics

GlycoMimetics logo

GlycoMimetics

Ovid Therapeutics logo

Ovid Therapeutics

Editas Medicine logo

Editas Medicine

Cowen Investment Management - Similar Investment Firms

Covey Capital Advisors logo

Covey Capital Advisors

coveycap.com

CaaS Capital Management logo

CaaS Capital Management

caascap.com

Invicta Management logo

Invicta Management

Cohen Capital Management logo

Cohen Capital Management

Coatue logo

Coatue

coatue.com

Cohesive Capital. logo

Cohesive Capital.

Wellington Management logo

Wellington Management

wellington.com

Cowin Venture logo

Cowin Venture

Brio Capital Management logo

Brio Capital Management

Pergament Lohas Fund logo

Pergament Lohas Fund

Fairmount Funds Management logo

Fairmount Funds Management

fairmountfunds.com

Alkeon Capital Management logo

Alkeon Capital Management

alkeoncapital.com

Deerfield Management logo

Deerfield Management

deerfield.com

Newtyn Management logo

Newtyn Management

newtyn.com

Alwyn Capital logo

Alwyn Capital

alwyncapital.com

Cowen Investment Management - Classification

Also Known As
  • Cowen Investment Management LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified